Literature DB >> 12834267

The 14-3-3 proteins: gene, gene expression, and function.

Yasuo Takahashi1.   

Abstract

14-3-3 proteins were discovered by Moore and Perez in the soluble extract of bovine brain. These proteins are highly abundant in the brain. In this review 14-3-3 cDNA cloning, nucleotide sequence of 14-3-3 cDNA, the structure of 14-3-3 gene and 14-3-3 gene expression, in situ hybridization of 14-3-3 mRNA in the brain, the function and regulation of 14-3-3 protein, the binding of 14-3-3 protein to other proteins, the effects of 14-3-3 protein on the binding of a protein to other proteins, and the effect on protein kinase, etc., are concisely described. From the recent rapid development of proteom technology, markedly more target proteins of 14-3-3 protein should be discovered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834267     DOI: 10.1023/a:1024296932670

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  73 in total

1.  Subcellular differences in post-translational modification of barley 14-3-3 proteins.

Authors:  M J van Zeijl; C Testerink; J W Kijne; M Wang
Journal:  FEBS Lett       Date:  2000-05-19       Impact factor: 4.124

2.  Involvement of 14-3-3 proteins in nuclear localization of telomerase.

Authors:  H Seimiya; H Sawada; Y Muramatsu; M Shimizu; K Ohko; K Yamane; T Tsuruo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.

Authors:  A Lopez-Girona; B Furnari; O Mondesert; P Russell
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

4.  14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules.

Authors:  C Vincenz; V M Dixit
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

5.  Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.

Authors:  A J Muslin; J W Tanner; P M Allen; A S Shaw
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

Review 6.  14-3-3: modulators of signaling proteins?

Authors:  D Morrison
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

7.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Authors:  A T Ferguson; E Evron; C B Umbricht; T K Pandita; T A Chan; H Hermeking; J R Marks; A R Lambers; P A Futreal; M R Stampfer; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins.

Authors:  L Zhang; J Chen; H Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

9.  Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases.

Authors:  P Dent; T Jelinek; D K Morrison; M J Weber; T W Sturgill
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

10.  14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor.

Authors:  J Liao; M B Omary
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  19 in total

1.  Case 8: absentminded and "walking like a drunk".

Authors:  Matthew A Joenig; Justin McArthur
Journal:  MedGenMed       Date:  2005-02-03

2.  Genetic mosaic dissection of Lis1 and Ndel1 in neuronal migration.

Authors:  Simon Hippenmeyer; Yong Ha Youn; Hyang Mi Moon; Kazunari Miyamichi; Hui Zong; Anthony Wynshaw-Boris; Liqun Luo
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

Review 3.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

4.  Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Authors:  Rukhsana Sultana; Renã A S Robinson; Fabio Di Domenico; Hafiz Mohmmad Abdul; Daret K St Clair; William R Markesbery; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-06-25       Impact factor: 4.044

5.  A polymorphism in the YWHAH gene encoding 14-3-3 eta that is not associated with sporadic Creutzfeldt-Jakob disease (CJD).

Authors:  Jisuk Yun; Byung-Hoon Jeong; Hae-Jung Kim; Young-Jae Park; Yun-Jung Lee; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

Review 6.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

7.  Screening for motility-associated genes in malignant astrocytoma cell lines.

Authors:  Hyang-Hwa Ryu; Shin Jung; Heung-Suk Sun; Tae-Young Jung; Shu-Guang Jin; Yong-Hao Jin; In-Young Kim; Young-Il Jeong; Sam-Suk Kang
Journal:  J Neurooncol       Date:  2006-10-18       Impact factor: 4.130

8.  Lack of association between 14-3-3 beta gene (YWHAB) polymorphisms and sporadic Creutzfeldt-Jakob disease (CJD).

Authors:  Byung-Hoon Jeong; Hyoung-Tae Jin; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 9.  14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology.

Authors:  Takahiko Umahara; Toshiki Uchihara
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

10.  Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.

Authors:  Yingchao Liu; Jinsong Wu; Guoquan Yan; Ruiping Hou; Dongxiao Zhuang; Luping Chen; Qi Pang; Jianhong Zhu
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.